RxDoctor Payments Data

Mary Youngblood, MD

Rheumatology · Lexington, KYNPI 1376734731

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for rheumatology clinicians in KY, where the typical reported total is $2,001.

$1,477in general payments, 2019–2025

Across 54 payments — averaging $27.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$222
  • AbbVie$216
  • Pfizer$180
  • Lilly USA, LLC$155
  • GSK$143
  • Regeneron Healthcare Solutions, Inc.$134
  • plus $428 from 8 others

What the payments were for

  • Food & beverage$1,476100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,477 in reported general payments places this provider in the 35th percentile of 81 rheumatology providers in Kentucky.

See all rheumatology providers in Kentucky

Medicare billing

Part B allowed, 2024
$9,844
Medicare patients
64
Services billed
152

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxychloroquine Sulfate47$1,932
Sulfasalazine DrSulfasalazine25$876
Leflunomide16$592
Prednisone65$461
MethotrexateMethotrexate Sodium20$422
Warfarin Sodium23$188
Omeprazole13$167
NitrofurantoinNitrofurantoin Macrocrystal13$94
Meloxicam27$92
Baclofen12$84

Paid to pharmacies, not to this prescriber.

Other rheumatology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →